Kala Pharmaceuticals's total assets for Q3 2024 were $54.08M, a decrease of -12.22% from the previous quarter. KALA total liabilities were $47.22M for the fiscal quarter, a -1.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.